5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection
RxNorm concept 2119714, clinical drug (scd). Prescribable name: trastuzumab-hyaluronidase-oysk 600 MG / 10,000 UNT in 5 mL Injection.
- RxCUI
- 2119714
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2119714 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
trastuzumab-hyaluronidase-oysk 600 MG / 10,000 UNT per 5 ML Injection; trastuzumab-oysk 600 MG / hyaluronidase-oysk 10,000 UNT per 5 ML Injection
Related concepts
- hyaluronidase-oysk 2000 UNT/ML (SCDC, consists of)
- trastuzumab-oysk 120 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection [Herceptin Hylecta] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2119714 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2119714 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2119714. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.